Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Benitec Biopharma (BNTC) Exchange Rate Effect (2019 - 2025)

Benitec Biopharma's Exchange Rate Effect history spans 7 years, with the latest figure at -$190000.0 for Q1 2025.

  • For Q1 2025, Exchange Rate Effect fell 265.22% year-over-year to -$190000.0; the TTM value through Mar 2025 reached -$5000.0, down 127.78%, while the annual FY2024 figure was -$8000.0, 101.94% down from the prior year.
  • Exchange Rate Effect for Q1 2025 was -$190000.0 at Benitec Biopharma, down from $285000.0 in the prior quarter.
  • Across five years, Exchange Rate Effect topped out at $501000.0 in Q3 2022 and bottomed at -$277000.0 in Q1 2022.
  • The 5-year median for Exchange Rate Effect is $21000.0 (2023), against an average of $42117.6.
  • The largest annual shift saw Exchange Rate Effect tumbled 1219.05% in 2022 before it surged 274.85% in 2024.
  • A 5-year view of Exchange Rate Effect shows it stood at -$54000.0 in 2021, then tumbled by 183.33% to -$153000.0 in 2022, then decreased by 6.54% to -$163000.0 in 2023, then soared by 274.85% to $285000.0 in 2024, then crashed by 166.67% to -$190000.0 in 2025.
  • Per Business Quant, the three most recent readings for BNTC's Exchange Rate Effect are -$190000.0 (Q1 2025), $285000.0 (Q4 2024), and -$95000.0 (Q3 2024).